The UK Research and Innovation’s (UKRI) Medical Research Council (MRC) and the UK’s National Institute for Health Research (NIHR) have announced a total of £4.3m in funding for six new projects looking at the disproportionate death rate of people from black, asian and minority ethnic (BAME) backgrounds from Covid-19.

Some of the projects will explore the creation of a new framework to ensure people from BAME backgrounds are represented in clinical trials testing treatments and vaccines for Covid-19.

Chief Medical Officer and Head of the NIHR Professor Chris Whitty said: “With evidence showing that people from BAME backgrounds are more severely affected by Covid-19, it is critical that we understand what factors are driving this risk to address them effectively.

“The diverse range of projects funded by the NIHR and UKRI will help examine this association in detail, so that new treatments and approaches to care can be developed to target the ethnicities most at risk.

“This research will have embedded patient and public involvement with Black, Asian and minority ethnic groups at all stages of the research.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.